A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors

Clinical trial NCT03734913 · UNKNOWN

Trial details

NCT number: NCT03734913
Sponsor: Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Basal Cell Carcinoma Medulloblastoma Adenocarcinoma of Esophagogastric Junction Small Cell Lung Cancer Neuroendocrine Neoplasm Glioblastoma

Start date: 2019-01-25
Primary completion: 2021-07-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.